Literature DB >> 11120836

A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses.

W Peters1, M Dupuis, I F Charo.   

Abstract

We have recently shown that mice with a targeted disruption of CCR2, the receptor for monocyte chemoattractant protein-1, have markedly impaired recruitment of macrophages to sites of inflammation. An unexpected finding in the CCR2(-/-) mice was a dramatic decrease in the production of IFN-gamma after challenge with purified protein derivative of Mycobacterium bovis. In this study, we have investigated the mechanism of this cytokine production defect. In vitro, direct activation of splenocytes with CD3/CD28 Abs failed to reveal any differences in IFN-gamma production between CCR2(+/+) and CCR2(-/-) mice. However, after immunization, the number of Ag-specific, IFN-gamma-producing cells in the draining lymph nodes was decreased by 70% in the CCR2(-/-) mice, suggesting an in vivo trafficking defect. Direct measurement of cell trafficking with fluorescently labeled CFA revealed a marked decrease in the number of monocytes/macrophages migrating to the site of immunization and to the draining lymph nodes in the CCR2(-/-) mice. The data suggest that impaired trafficking of APCs in the CCR2(-/-) mice contributes to the defect in IFN-gamma production. These data support the idea that CCR2-positive monocytes/macrophages are critical in linking the innate and adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120836     DOI: 10.4049/jimmunol.165.12.7072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Langerhans cells renew in the skin throughout life under steady-state conditions.

Authors:  Miriam Merad; Markus G Manz; Holger Karsunky; Amy Wagers; Wendy Peters; Israel Charo; Irving L Weissman; Jason G Cyster; Edgar G Engleman
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

2.  Impaired lung dendritic cell activation in CCR2 knockout mice.

Authors:  Bo-Chin Chiu; Christine M Freeman; Valerie R Stolberg; Jerry S Hu; Kyriaki Zeibecoglou; Bao Lu; Craig Gerard; Israel F Charo; Sergio A Lira; Stephen W Chensue
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 3.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

4.  Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.

Authors:  W B Breunis; M H Biezeveld; J Geissler; I M Kuipers; J Lam; J Ottenkamp; A Hutchinson; R Welch; S J Chanock; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

5.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

Authors:  W Peters; H M Scott; H F Chambers; J L Flynn; I F Charo; J D Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

6.  CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection.

Authors:  Kaifeng Lisa Lin; Shari Sweeney; Brian Donghoon Kang; Elizabeth Ramsburg; Michael Dee Gunn
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

Review 7.  Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.

Authors:  Kyung-Rok Yu; Hannah Natanson; Cynthia E Dunbar
Journal:  Hum Gene Ther       Date:  2016-08-02       Impact factor: 5.695

8.  CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation.

Authors:  A E Gelman; M Okazaki; S Sugimoto; W Li; C G Kornfeld; J Lai; S B Richardson; F H Kreisel; H J Huang; J R Tietjens; B H Zinselmeyer; G A Patterson; M J Miller; A S Krupnick; D Kreisel
Journal:  Am J Transplant       Date:  2010-05       Impact factor: 8.086

9.  Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression.

Authors:  Holly M Scott; JoAnne L Flynn
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

10.  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.

Authors:  Elena E Perez; Jianbin Wang; Jeffrey C Miller; Yann Jouvenot; Kenneth A Kim; Olga Liu; Nathaniel Wang; Gary Lee; Victor V Bartsevich; Ya-Li Lee; Dmitry Y Guschin; Igor Rupniewski; Adam J Waite; Carmine Carpenito; Richard G Carroll; Jordan S Orange; Fyodor D Urnov; Edward J Rebar; Dale Ando; Philip D Gregory; James L Riley; Michael C Holmes; Carl H June
Journal:  Nat Biotechnol       Date:  2008-06-29       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.